Drug class
Antimitotic Agents clinical trials
A class of medicines: the studies that test any of its 127 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.
Keep track of what changes. Save the antimitotic agents studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesMedicines in this class
Studies that test each. A study of two counts under both, and once above.
And 87 more, each tested in fewer studies.
Studies by the year they started
5,012 studies that test it; most in 2007 (244); 6 more planned to start later
| Year | Studies |
|---|---|
| 1990 | 2 |
| 1991 | 1 |
| 1992 | 3 |
| 1993 | 3 |
| 1994 | 15 |
| 1995 | 17 |
| 1996 | 36 |
| 1997 | 64 |
| 1998 | 88 |
| 1999 | 114 |
| 2000 | 115 |
| 2001 | 135 |
| 2002 | 149 |
| 2003 | 176 |
| 2004 | 207 |
| 2005 | 211 |
| 2006 | 220 |
| 2007 | 244 |
| 2008 | 234 |
| 2009 | 184 |
| 2010 | 188 |
| 2011 | 183 |
| 2012 | 157 |
| 2013 | 163 |
| 2014 | 193 |
| 2015 | 181 |
| 2016 | 170 |
| 2017 | 167 |
| 2018 | 164 |
| 2019 | 155 |
| 2020 | 178 |
| 2021 | 179 |
| 2022 | 150 |
| 2023 | 154 |
| 2024 | 146 |
| 2025 | 150 |
| 2026 | 116 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1,272 · Other 3,780
National Cancer Institute (NCI) (216) · M.D. Anderson Cancer Center (138) · Sanofi (93) · Memorial Sloan Kettering Cancer Center (86) · Fudan University (72) · Alliance for Clinical Trials in Oncology (64) · Children's Oncology Group (60) · SWOG Cancer Research Network (58)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.
Testing one of them · 5,052
- Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialRecruitingPhase 3National Cancer Institute (NCI)NCT06096844Written as Nab-paclitaxel
- Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract CancerRecruitingPhase 2/3National Cancer Institute (NCI)NCT04628767Written as Vinblastine Sulfate
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabRecruitingPhase 3National Cancer Institute (NCI)NCT05675410Written as Vincristine Sulfate
- Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell LymphomaRecruitingPhase 2National Cancer Institute (NCI)NCT04002947Written as CHOP
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialRecruitingPhase 2National Cancer Institute (NCI)NCT05564377Written as Paclitaxel
- Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLCRecruitingPhase 2CatalYm GmbHNCT07246863Written as Docetaxel
- Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck CancerRecruitingPhase 2National Cancer Institute (NCI)NCT07195734Written as Paclitaxel
- Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker DeclineRecruitingPhase 2Blokhin's Russian Cancer Research CenterNCT07847190Written as Paclitaxel
- Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel CancersRecruitingPhase 2SWOG Cancer Research NetworkNCT04205968Written as Paclitaxel
- Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCCRecruitingPhase 2Fujian Medical University Union HospitalNCT06601309Written as Paclitaxel+Cisplatin(Concurrent Chemoradiotherapy)
- Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerRecruitingPhase 3National Cancer Institute (NCI)NCT06058377Written as Paclitaxel
- A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic CancerRecruitingPhase 1/2Theriva Biologics SLNCT07701486Written as Nab-paclitaxel + Gemcitabine
- Randomized Interventional Clinical Trial on the Prevention of Atrial Fibrillation Using Colchicine, Amiodarone And a Posterior Pericardiotomy.Not yet recruitingPhase 3ElsanNCT07887022Written as Colchicine
- MRD and Imaging Guided Adaptive Neoadjuvant Therapy for Resectable NSCLCNot yet recruitingPhase 2Peking University People's HospitalNCT07885709Written as Nab-paclitaxel
- A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).RecruitingPhase 1/2Merck Sharp & Dohme LLCNCT06843447Written as Paclitaxel
- Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaNot yet recruitingPhase 1Northwestern UniversityNCT07594548Written as Paclitaxel
- Two Part (Phase1b/ Phase3) Trial of Subcutaneous Dostarlimab Plus Carboplatin-Paclitaxel in Participants With Primary Advanced or Recurrent Endometrial CancerNot yet recruitingPhase 3GlaxoSmithKlineNCT07860450Written as Carboplatin and paclitaxel
- PDT For Induction Therapy For Head And Neck CancerRecruitingPhase 2Massachusetts General HospitalNCT07214987Written as Docetaxel
- Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO TrialRecruitingPhase 2University of WashingtonNCT07698535Written as Docetaxel
- PD-1 Blockade Alone Versus in Combination With Chemotherapy as First Line Therapy in Females With Advanced NSCLC & PD-L1 Expression ≥50%Not yet recruitingPhase 3German Cancer Research CenterNCT07877584Written as nab-Paclitaxel (100 mg/m² )
See all 5,052 studies that test one of the antimitotic agents →